
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$807.78M
Market Cap
-
P/E Ratio
-0.69
EPS
$3.80
52 Week High
$0.76
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $315M |
| Total Current Assets | $310M |
| Cash And Cash Equivalents At Carrying Value | $46M |
| Cash And Short Term Investments | $46M |
| Inventory | - |
| Current Net Receivables | $5.3M |
| Total Non Current Assets | $5.4M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $248M |
| Other Current Assets | $10M |
| Other Non Current Assets | - |
| Total Liabilities | $286M |
| Total Current Liabilities | $45M |
| Current Accounts Payable | $2.3M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $961K |
| Total Non Current Liabilities | $241M |
| Capital Lease Obligations | $5.4M |
| Long Term Debt | $198M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $203M |
| Other Current Liabilities | $25M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $29M |
| Treasury Stock | - |
| Retained Earnings | -$1.3B |
| Common Stock | $23K |
| Common Stock Shares Outstanding | $226M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Gossamer Bio, Inc. is a San Diego-based clinical-stage biopharmaceutical firm focused on the discovery and development of innovative therapies for immunology, inflammation, and oncology. With a robust pipeline that employs advanced scientific insights, Gossamer Bio addresses significant unmet medical needs through its diverse range of drug candidates. As it progresses through clinical trials, the company is committed to providing transformative treatment options for patients with complex diseases, establishing itself as an influential player in the biopharmaceutical sector.